Prosecution Insights
Last updated: October 26, 2026

Amy Rose Hudson, USPTO Patent Examiner

Listed by the USPTO as HUDSON, AMY ROSE

Tech Center 4100 • Art Units: 1635 1636 1674 1682 4100

This examiner grants 75% of resolved cases

Analysis

HUDSON, AMY ROSE works in Tech Center 4100 and Art Unit 1635. Across 1462 resolved cases, the allowance rate is 74.8%, the interview lift is 11.7%, and the median time to allowance is 895 days. The extensive case history makes these figures a useful basis for setting prosecution expectations, while the interview effect appears modest.

Alnylam Pharmaceuticals Inc., University of Virginia Patent Foundation, and Sanofi S.A. are the listed companies. MCCARTER & ENGLISH, LLP, MARSHALL, GERSTEIN & BORUN LLP, and Casimir Jones, S.C. are the listed firms. Practitioners can emphasize well-supported written amendments and use interviews selectively to resolve specific issues.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

74.8%
Allow Rate
+14.8% vs TC avg
1,532
Total Applications
+11.7%
Interview Lift
895
Avg Prosecution Days
Based on 1462 resolved cases, 2023–2026

Rejection Statute Breakdown

3.5%
§101 Eligibility
13.8%
§102 Novelty
33.7%
§103 Obviousness
35.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17925328 METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE SYNDROME Non-Final OA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
18516523 PLASMA CELL-FREE RNA AND METHODS OF USE THEREOF AS NON-INVASIVE BIOMARKERS FOR ALZHEIMER'S DISEASE Non-Final OA WASHINGTON UNIVERSITY
18316981 COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY Final Rejection University of Virginia Patent Foundation
18306680 THERAPEUTIC TARGETING OF ACTIVATED AVIL-INDUCED SARCOMAS Final Rejection University of Virginia Patent Foundation
17638518 REACTIVATING P53 MUTANTS FOR CANCER TREATMENT BY TARGETING PROLIDASE (PEPD) Non-Final OA Health Research, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amy Rose Hudson's allowance rate?

74.8% of resolved applications examined by Amy Rose Hudson were allowed (1,462 resolved cases), compared with 51.6% across Art Unit 1635 over the last five years.

Does an interview help with examiner Amy Rose Hudson?

This examiner's interview lift is +11.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amy Rose Hudson take to allow a patent?

Applications allowed by Amy Rose Hudson took 895 days on average from filing to allowance.

Which art unit does examiner Amy Rose Hudson work in?

Amy Rose Hudson examines applications in Art Unit 1635 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month